Here are seven things to know:
1. The company reported U.S. GAAP net income of $12.3 million as compared to $10.2 million for the third quarter ended April 30, 2014.
2. Sales saw an 18 percent increase to a record $141,508,000 for the quarter ended April 30, 2014.
3. For the nine months ended April 30, 2015, the company reported U.S. GAAP net income of $34.6 million. The net income for the nine months ended April 30, 2014, was $32.5 million.
4. Under non-GAAP measures, adjusted net income increased 19 percent in this quarter to $14.6 million.
5. The Medivators endoscopy business delivered organic sales growth of 17 percent in the quarter.
6. Compared with the same quarter last year, Cantel Medical’s adjusted EBITDAS grew by 19 percent to $27.9 million.
7. Also, the company’s net debt position increased by $17 million to $66.1 million during the first nine months of fiscal year 2015.
More articles on GI/endoscopy:
Underwriters of EndoChoice IPO to purchase additional shares
American Journal of Gastroenterology features updates on biomarker advances
GI physician to know: Dr. John Petrini of Sansum Clinic’s Pueblo Multi-Specialty Clinic
